Jason Novak focuses his practice on intellectual property transactions, diligence, procurement and portfolio management for clients in the personalized/precision medicine (e.g., genomic sequencing platforms, computational genomics/bioinformatics, molecular diagnostics, etc.), digital health, life sciences tooling (e.g., qPCR, dPCR, capillary electrophoresis, etc.), medical device and food industries. He has extensive experience in intellectual property strategy and patent portfolio management, preparation and prosecution, oppositions, counseling, licensing and technology transactions, in and out-licensing, freedom-to-operate, various types of due diligence, IP training, risk recognition and management, and dispute resolution.
Previously, Jason was a director IP counsel for a multinational, biotechnology company. He managed worldwide intellectual property needs in genetic sciences instrumentation and software. Jason managed, for example, large IP portfolios, a team of agents and attorneys, licensing programs, various diligence needs, various IP related contract needs, and foreign and domestics patent challenges. Before transitioning to the legal industry, Jason was a research engineer for a leading food product company, where he led numerous product and process redesigns, reformulations and launches. This cross-functional role required interaction and experience with operations, finance, marketing and regulatory areas. This previous experience has contributed to his knowledge in dealing with various corporate functions from both an R&D and legal perspective.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.